<?xml version="1.0" encoding="UTF-8"?>
<ref id="B103-viruses-12-00339">
 <label>103.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Bucheit</surname>
    <given-names>A.D.</given-names>
   </name>
   <name>
    <surname>Kumar</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Grote</surname>
    <given-names>D.M.</given-names>
   </name>
   <name>
    <surname>Lin</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>von Messling</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Cattaneo</surname>
    <given-names>R.B.</given-names>
   </name>
   <name>
    <surname>Fielding</surname>
    <given-names>A.K.</given-names>
   </name>
  </person-group>
  <article-title>An oncolytic measles virus engineered to enter cells through the CD20 antigen</article-title>
  <source>Mol. Ther.</source>
  <year>2003</year>
  <volume>7</volume>
  <fpage>62</fpage>
  <lpage>72</lpage>
  <pub-id pub-id-type="doi">10.1016/S1525-0016(02)00033-3</pub-id>
  <pub-id pub-id-type="pmid">12573619</pub-id>
 </element-citation>
</ref>
